We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
- Authors
Eckardt, John R; von Pawel, Joachim; Pujol, Jean-Louis; Papai, Zsolt; Quoix, Elisabeth; Ardizzoni, Andrea; Poulin, Ruth; Preston, Alaknanda J; Dane, Graham; Ross, Graham
- Abstract
Single-agent intravenous (IV) topotecan is an effective treatment for small-cell lung cancer (SCLC) after failure of first-line chemotherapy. This open-label, randomized, phase III study compared oral and IV topotecan in patients with SCLC sensitive to initial chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 15, p2086
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.08.3998